AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of AbbVie Inc. (ABBV) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of AbbVie Inc. (ABBV) stock worth $1K-$15K in a STOCK Act filing on Mar 18, 2022.
The trade happened on Feb 18, 2022, 28 days before it was made public.
ABBV has moved +82.5% since the trade date, from $144.03 to $262.90 (Oct 2, 2026 close).
- Traded
- Feb 18, 2022
- Disclosed
- Mar 18, 2022
- Filing delay
- 28 days
- Price since
- +82.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (36)
- SellMSFT$1M-$5MMar 18, 2022
- BuyMSFT$1M-$5MMar 18, 2022
- SellMSFT$500K-$1MMar 18, 2022
- BuyMSFT$500K-$1MMar 18, 2022
- BuyMSFT$500K-$1MMar 18, 2022
- SellMSFT$250K-$500KMar 18, 2022
- SellMSFT$250K-$500KMar 18, 2022
- SellINTC$15K-$50KMar 18, 2022
- BuyABBV$1K-$15KMar 18, 2022
- SellAFRM$1K-$15KMar 18, 2022
- SellALGN$1K-$15KMar 18, 2022
- BuyENPH$1K-$15KMar 18, 2022
- SellETSY$1K-$15KMar 18, 2022
- SellFB$1K-$15KMar 18, 2022
- BuyFIS$1K-$15KMar 18, 2022
- BuyICUI$1K-$15KMar 18, 2022
- BuyINTU$1K-$15KMar 18, 2022
- BuyKO$1K-$15KMar 18, 2022
- BuyKO$1K-$15KMar 18, 2022
- BuyLOW$1K-$15KMar 18, 2022
More ABBV insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.